Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology ...
Alcon has agreed to acquire the medical-technology company Lensar in a deal that could be worth up to $430 million. The eye-care company said Monday that it would pay $14 for each Lensar share in cash ...
Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser ...
Investor's Business Daily on MSN7d
Alcon Trying To Close In On Key Technical BenchmarkIn a welcome move, Alcon saw its Relative Strength Rating rise from 68 to 71 on Tuesday. Please watch the video at Investors.com - How To Buy Stocks: Do You Know Your Stock's Personality Type? IBD's ...
Investing.com -- Alcon (SIX: ALCC) has received an upgrade to a "buy" rating from BofA Securities in a note dated Tuesday, signaling the beginning of an earnings growth cycle for the Swiss eye care ...
With the company strategically growing through innovation and market expansion, we expect the stock to continue its upward movement in the coming days. Alcon is experiencing inflationary pressures ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback